Session » Poster Breakout 4 – Updates on Therapeutics
The 2020 Pediatric Rheumatology Symposium, originally scheduled for April 29 – May 2, was postponed due to COVID-19; therefore, abstracts were not presented as scheduled.
Date: Friday, May 1, 2020
Time: 4:30PM-5:00PM
- 4:30PM-5:00PM
-
Abstract Number: 028
A Randomized, Double-blind, Placebo-controlled Study of Anakinra in Pediatric and Adult Patients with Still’s Disease
- 4:30PM-5:00PM
-
Abstract Number: 026
Allogeneic Hematopoietic Cell Transplantation (HCT) in the National Institutes of Health (NIH)’s Deficiency of Adenosine Deaminase 2 (DADA2) Patient Cohort
- 4:30PM-5:00PM
-
Abstract Number: 027
Clinical Features and Outcomes in Chronic Atypical Neutrophilic Dermatosis with Lipodystrophy and Elevated Temperature (CANDLE) Syndrome: Before and After JAK-inhibition